Excision BioTherapeutics

0 followers

‌

Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections.

Industries

Biotechnology, Education

Headquarters

San Francisco, United States

Employees

11-50

Links

Org chart

Daniel Dornbusch

CEO

Daniel Dornbusch

Collapse

TJ Cradick

Chief Scientific Officer

Christine Silverstein

CFO

CTO

General Counsel

SVP, Clinical

Senior Director, Genome Editing

Helen Zhao

Senior Director, Project Management

Panos Argiras

Senior Director, External Manufacturing

Adam Dunko

Director, Quality Assurance

Qin Xiang

Director, Analytical Development & QC

Lucas Buchheim-Jurisson

Associate Director, Corporate Strategy

Karina Dias Teixeira

Senior Scientist, Molecular Biology

Pamela Castillo

Senior Corporate Development Associate

Teams

+27

Corporate Governance and Strategy

30 members

+10

Scientific Research and Development

13 members

Leadership Team

4 members

Similar companies

Immunome

2 followers

Day One Biopharmaceuticals

1 follower

Othram

1 follower

SOPHiA GENETICS

4 followers

KIPP DC Public Schools

289 followers

Thermo Fisher Scientific

165 followers

Gilead Sciences

128 followers

Regeneron

93 followers

Pearson

59 followers

Alexion Pharmaceuticals

34 followers

McGraw-Hill

24 followers

Explore companies